AnalystsOlivia BrayerOlivia Brayer's Stock Forecasts
AnalystsOlivia Brayer
Sectors:
Industries:
Analyst Ranking
Top 32%
#1595 out of 5020 analysts
Average Return
+2.12%
Win Rate
43%24 out of 56
Risk vs Reward
Poor
Good
Olivia Brayer's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Aurinia Pharmaceuticals IncAUPH | +79.66% | $7.13 | $12.81 | 2024-09-15 - 2025-09-15 | Strong Buy |
Aurinia Pharmaceuticals IncAUPH | +79.04% | $6.87 | $12.30 | 2024-09-08 - 2025-09-08 | Strong Buy |
Vertex Pharmaceuticals IncVRTX | +41.12% | $358.40 | $505.78 | 2023-08-01 - 2024-08-01 | Strong Buy |
Vertex Pharmaceuticals IncVRTX | +36.06% | $343.96 | $468.00 | 2023-09-06 - 2024-09-06 | Strong Buy |
Vertex Pharmaceuticals IncVRTX | +35.77% | $343.00 | $465.70 | 2023-11-15 - 2024-11-15 | Strong Buy |
Olivia Brayer Analyst Color
Get additional color on Olivia Brayer's coverage of popular stocks
Olivia Brayer's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
United Therapeutics CorpUTHR | 2 | Strong Buy | $525.00 | +30.05% | Maintains | 8 days ago |
Verona Pharma PLCVRNA | 1 | Strong Buy | $100.00 | -5.92% | Maintains | 3 months ago |
Vanda Pharmaceuticals IncVNDA | 1 | Strong Buy | $13.00 | +196.13% | Assumes | 4 months ago |
Biomarin Pharmaceutical IncBMRN | 14 | Strong Buy | $90.00 | +65.53% | Reiterates | 7 months ago |
Vertex Pharmaceuticals IncVRTX | 22 | Strong Buy | $480.00 | +23.98% | Reiterates | 7 months ago |
Bristol Myers Squibb CoBMY | 9 | Hold | $55.00 | +19.18% | Maintains | 7 months ago |
Gilead Sciences IncGILD | 10 | Hold | $80.00 | -28.74% | Reiterates | 9 months ago |
Regeneron Pharmaceuticals IncREGN | 8 | Hold | $1,015.00 | +73.36% | Reiterates | a year ago |
Amgen IncAMGN | 2 | Strong Buy | $405.00 | +47.43% | Reiterates | a year ago |
Alnylam Pharmaceuticals IncALNY | 19 | Hold | $220.00 | -51.30% | Reiterates | a year ago |
Aurinia Pharmaceuticals IncAUPH | 5 | Strong Buy | $10.00 | N/A | Reiterates | a year ago |
Mannkind CorpMNKD | 3 | Strong Buy | $6.50 | N/A | Reiterates | a year ago |
Crispr Therapeutics AgCRSP | 1 | Strong Buy | $72.00 | N/A | Initiates Coverage On | 2 years ago |
Lenz Therapeutics IncLENZ | 2 | Hold | $3.00 | N/A | Downgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.